CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Honoring the Leaders and Innovators of Immunotherapy at CRI’s 2024 Awards Gala

    The Cancer Research Institute (CRI) hosted its 2024 Annual Awards Gala on Tuesday, October 15, at Cipriani…
    October 22, 2024| Max Mallet
  • CICON24 Recap: Key Breakthroughs and Bold Conversations Shaping the Future of Immunotherapy

    The Cancer Immunotherapy Conference (CICON24) opened with a palpable sense of urgency and optimism, bringing together the…
    September 17, 2024| Ajit Muley, PhD
  • Translating Science into Survival at the 8th Annual CICON Conference 

    CRI is proud to co-host the eighth annual Cancer Immunotherapy Conference (CICON) alongside the European Network for…
    August 2, 2024| Max Mallet
  • 10 Attractions to Visit in and around Washington, D.C. While Attending CICON24 

    The eighth annual CRI-ENCI Cancer Immunotherapy Conference (CICON24) kicks off on September 8 in National Harbor, Maryland….
    July 2, 2024| Max Mallet
  • ASCO 2023 Preview — Partnering with Patients: The Cornerstone of Cancer Care and Research

    This weekend, the highly anticipated 2023 annual meeting of the American Society of Clinical Oncologists (ASCO) takes…
    June 1, 2023| Arthur N. Brodsky, PhD
  • <strong><u>AACR 2023 Recap: CRI Scientists Tackle the Frontiers of Cancer Immunotherapy</u></strong>

    More than any conference yet, the 2023 annual meeting of the American Association for Cancer Research (AACR…
    April 20, 2023| Arthur N. Brodsky, PhD
  • <strong>E. John Wherry, PhD, Receives 2023 AACR-CRI Lloyd J. Old Award in Cancer Immunology</strong>

    E. John Wherry, PhD — the director of the Institute for Immunology, chair of the Department of…
    April 17, 2023| Arthur N. Brodsky, PhD
  • AACR 2023 Preview: Advancing the Frontiers of Cancer Science and Medicine

    From April 14-19, the 2023 AACR annual meeting highlights a broad scope of immunotherapy breakthroughs, including cell…
    April 10, 2023| Arthur N. Brodsky, PhD
  • ASCO 2022 Preview: The Latest Insights from the Front Lines of Cancer Immunotherapy

    CRI’s PRINCE Trial featured at ASCO22, along with sessions that highlight the latest clinical advances in checkpoint…

    June 2, 2022| Arthur N. Brodsky, PhD
1 2 3 … 15
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute